211 related articles for article (PubMed ID: 30799531)
1. [Interpretation of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition)].
Yuan Y; Chen X; Hu J; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):101-106. PubMed ID: 30799531
[TBL] [Abstract][Full Text] [Related]
2. [Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (Edition 2024)].
; ; ; ;
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Feb; 27(2):109-126. PubMed ID: 38413076
[TBL] [Abstract][Full Text] [Related]
3. [Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition)].
Chen L; Hu J; Ji J; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):961-975. PubMed ID: 30269314
[TBL] [Abstract][Full Text] [Related]
4. [Interpretation of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction(2024 edition)].
Liu K; Zhu YF; Yang YS; Chen LQ; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Feb; 27(2):127-131. PubMed ID: 38413077
[TBL] [Abstract][Full Text] [Related]
5. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery].
Li ZY; Gu YM; Wang WP; Chen LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820
[TBL] [Abstract][Full Text] [Related]
7. [Retrospect of 2019: focus on the surgical treatment for adenocarcinoma of esophagogastric junction].
Yan CY; Chen LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):20-25. PubMed ID: 31958926
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of esophagogastric junction tumors.
von Rahden BH; Stein HJ; Siewert JR
World J Gastroenterol; 2006 Nov; 12(41):6608-13. PubMed ID: 17075972
[TBL] [Abstract][Full Text] [Related]
9. [Dilemmas in definition and classification of adenocarcinoma of esophagogastric junction: from history to current status].
Chen L; Liu FL
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):813-818. PubMed ID: 36058706
[TBL] [Abstract][Full Text] [Related]
10. [Minimally invasive surgery in adenocarcinoma of esophagogastric junction].
Zang L; Li S; Zheng M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):875-880. PubMed ID: 30136267
[TBL] [Abstract][Full Text] [Related]
11. [To improve the cognition about the carcinoma of esophagogastric junction].
Xue YW; Yu XF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):125-7. PubMed ID: 23446469
[TBL] [Abstract][Full Text] [Related]
12. Treatment of esophagogastric junction carcinoma: an unsolved debate.
Orditura M; Galizia G; Lieto E; De Vita F; Ciardiello F
World J Gastroenterol; 2015 Apr; 21(15):4427-31. PubMed ID: 25914451
[TBL] [Abstract][Full Text] [Related]
13. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
14. [Treatment Strategy for Esophagogastric Junction Carcinoma;Highly Controversial Topic in the Upper Gastrointestinal Malignancy].
Yamashita H; Seto Y
Kyobu Geka; 2017 Jan; 70(1):72-79. PubMed ID: 28174399
[TBL] [Abstract][Full Text] [Related]
15. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
16. [Chinese consensus on definition and grading of perioperative morbidities in esophageal cancer and esophagogastric junction cancer (2023 Edition)].
; ; ;
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(46):3760-3769. PubMed ID: 38092553
[TBL] [Abstract][Full Text] [Related]
17. [Chinese expert consensus on surgical continuous quality improvement goals in esophageal cancer and esophagogastric junction cancer (2024 edition)].
; ; ;
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1804-1811. PubMed ID: 38782748
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
[No Abstract] [Full Text] [Related]
19. [Current status and progression of minimally invasive surgery after neoadjuvant therapy for adenocarcinoma of esophagogastric junction].
Zhao EH; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):141-146. PubMed ID: 35176826
[TBL] [Abstract][Full Text] [Related]
20. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
